HMOX1 and breast cancer: HMOX1 has been previously shown to be involved in drug resistance of breast cancer cells by preventing apoptosis and autophagy, since siRNA knockdown of HMOX1 enhanced the cytotoxicity of doxorubicin in MDA-MB-231 and BT549 cells [18,19].